Summary Some patients with citrin deficiency caused by SLC25A13 gene mutations develop adult-onset type II citrullinemia (CTLN2) with hepatic encephalopathy. A recent nutritional survey of 18 citrin-deficient subjects (age 1-33 y) confirmed a marked decrease in carbohydrate intake compared to an age-matched general Japanese population. However, a quantitative understanding of food intake in CTLN2 patients remains unclear, although qualitative dietary information has been reported. In order to elucidate the characteristics of daily nutrition of CTLN2 patients, the food intake of 5 male patients (age 39-52 y) was investigated in detail by the Food Frequency Questionnaire. In the present survey, the mean energy ratio of protein : fat : carbohydrate (PFC ratio) of the 5 patients was 19 Ϯ 3% : 44 Ϯ 5% : 37 Ϯ 4%, which was almost identical to previously reported data in younger citrindeficient subjects (19 Ϯ 2% : 44 Ϯ 5% : 37 Ϯ 7%). Cereal intake was especially low in all CTLN2 patients at 309 Ϯ 33 g/d (56% of control), compared to that in an age-matched general Japanese population (553 Ϯ 197 g/d). Additionally, CTLN2 patients preferred high fat and protein foods. Commonly, fat intake declines with age in the general Japanese population, but this tendency was not observed in the 5 CTLN2 patients. The present results suggest that intakes of low-carbohydrate, high-protein and high-fat food was characteristic the 5 CTLN2 patients surveyed, as has been previously reported in younger citrin-deficient subjects, and that the PFC ratio may not be influenced by age or CTLN2-onset.
Citrin is a liver-type mitochondrial aspartate (Asp)-glutamate (Glu) carrier (AGC) ( 1 ) . Citrin deficiency, caused by a mutation of the SLC25A13 gene ( 2 ) , is an autosomal recessive disorder which leads to neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD) and adult-onset type II citrullinemia (CTLN2) ( 3 , 4 ) . Patients with CTLN2 present with intractable hepatic encephalopathy, with various neuropsychotic manifestations ( 5 ) . One distinct feature of citrin deficiency is that most individuals with the disorder, including asymptomatic CTLN2 patients, have a peculiar fondness for protein-and fat-rich foods such as beans and peanuts, and an aversion to carbohydrate-rich foods such as rice and sweets ( 3 ) . It is assumed that their unusual food preference is directly related to the underlying pathophysiology ( 5 ) .
The function of citrin as AGC in the hepatocytes is to supply the cytosol with mitochondrial aspartate, the substrate of argininosuccinate synthetase (ASS) ( 3 , 4 ) . In addition, as one component of the malate-Asp shuttle (MAS), citrin transports cytosolic nicotinamide adenine dinucleotide (NADH) reducing equivalents into the mitochondria ( 1 , 4 ) . Therefore, in citrin deficiency, the cytosolic NADH/NAD ϩ ratio should be significantly increased following carbohydrate metabolism, resulting in urea cycle insufficiency ( 4 ) . Moreover, accumulation of cytosolic NADH activates the malate-citrate shuttle compensating for hepatic AGC insufficiency, causing overproduction of fatty acids in hepatocytes ( 4 ) . Hence, glucose overloading should be harmful in citrin-deficient subjects ( 6 ) . Indeed, it has been recently reported that a CTLN2 patient had a rapid deterioration after consuming the conventional low-protein diet for hepatic encephalopathy ( 7 ) . Furthermore, Saheki et al. reported recently an interesting and important case: a 13-y-old girl with early-stage or pre-CTLN2 ( 8 ) . When she consumed hospital meals with high-carbohydrate energy ratios, she showed significant increases in plasma ammonia and citrulline, and became drowsy. When she changed to her favorite meals with proteinand fat-rich and carbohydrate-low meals, only a slight increase in plasma ammonia with no increase in citrulline resulted. Thus, inappropriate nutrition can cause aggravation of symptoms and a poor clinical outcome in this disorder.
Recently, a quantitative study on food intake of young citrin-deficient subjects aged 1 to 33 y has been described ( 9 ) . However, food intake remains unclear in CTLN2 patients, although qualitative information on food intake has been reported ( 5 ). While the onset age of CTLN2 varies in each patient and has been reported to range from 11 to 79 y ( 10 ), neuropsychological symptoms of CTLN2 begin in the third to fifth decade in most patients. Thus, in order to establish an appropriate hospital meal for citrin-deficient subjects and CTLN2 patients, quantitative characteristics of food-intake in CTLN2 patients need to be evaluated, and whether the differences in food preference exist among the age and/ or between with and without CTLN2-onset needs to be defined. In the present study, food intakes in 5 CTLN2-onset patients aged 39-52 y without diet therapy were surveyed in detail.
MATERIALS AND METHODS

Patients.
Five male CTLN2 patients ranging in age from 39 to 52 y (mean 48 Ϯ 6 y) who had been admitted to Shinshu University Hospital were examined in this study. The clinical and laboratory data of the 5 patients are shown in Tables 1 and 2 , respectively. All patients suffered from repeated encephalopathic symptoms including disturbed consciousness and abnormal behavior with elevated plasma levels of ammonia and citrulline. The diagnosis of citrin deficiency was confirmed by DNA analysis of the SLC25A13 gene ( 2 , 11 , 12 ) . Two of the patients (patients 1 and 3) have been reported previously ( 7 , 13 ) . In patient 1, the meal after hospitalization without diet therapy or drug therapy was surveyed. Patient 2 had begun drug therapy at the time of the survey, and his plasma ammonia was controlled by oral administration of L -arginine. His doctor had recommended that he should "not eat too many The presence of fatty liver was evaluated by means of liver histology or imaging. AST, aspartate aminotransferase; ALT, alanine aminotransferase; PSTI, pancreatic secretory trypsin inhibitor.
carbohydrates"; however, the specific quantity of carbohydrate intake was not specified. In patients 3, 4 and 5, the meal before hospitalization was surveyed, i.e., when the patients were not under a diet or drug therapy. Two patients had a low body mass index (BMI). The median weight and BMI values were lower than those of the controls (57.9 Ϯ 10.4 kg vs 69.7 Ϯ 10.1 kg, and 19.9 Ϯ 3.5 kg/m 2 vs 24.0 Ϯ 3.2 kg/m 2 , respectively, p Ͻ 0.01). Patients 1 and 2 had blood samples obtained at the time of the nutrition survey, and patients 3, 4 and 5 had blood samples obtained at admission. Three patients showed a slight elevation of serum levels of ALT and AST. Two patients had hypertriglyceridemia. Plasma ammonia was almost within normal limits in 4 patients. Plasma citrulline was high in all patients, and serum PSTI, which is a diagnostic marker of CTLN2 ( 14 ) , was also high in all patients. Fatty liver was observed in all patients.
Evaluation of food intake. To assess daily food intakes of the patients, the Food Frequency Questionnaire (FFQg ver. 2.0 for Windows, Kenpakusha, Tokyo, Japan) was used. Intake of 18 food groups, energy, and 34 macro-and micro-nutrients was assessed by this program ( 15 ) . The FFQ is a method of estimating intake of food groups and nutrients from the portion size and the food frequency with 1 wk as a unit. The FFQ consists of 20 question groups composed of 29 food groups and 10 kinds of cooking methods. The subjects were shown portion-sized pictures of food items and asked the quantity of each food intake and how often they consumed such foods in a week. Each subject was interviewed by a dietitian to confirm the portion size and the frequency of food eaten. The intake of each food item was estimated by multiplying the portion size by their intake frequency. Nutrient intake can also be assessed by establishing a database of compositions of the food items for target nutrients. The intake of each nutrient was calculated using the following formula for each item: (reported intake frequency per day) ϫ (portion size in gram) ϫ (nutrient content per 100 g)/100. The intake was then summed for all the listed food items to obtain the intake per day. Reference values from a national nutrition survey for the general Japanese population, stratified by age and sex, were previously compiled in 2006 by the Ministry for Health, Labor and Welfare in Japan (http://www.mhlw.go.jp/bunya/kenkou/eiyou06/ pdf/01-01a.pdf; data only available in Japanese).
Ethics. The nutritional survey was done in the past for the purpose of the treatment, not for research. We reviewed the data of the patients who were already hospitalized many years ago; therefore we could not obtain informed consent from each patient. Although this study was not reviewed by Committee for Ethics, Shinshu University Hospital announced to all patients that their data may be used in the future with considering privacy. Those who do not want to be used for research purposes or case reports can claim an exemption.
Statistical analysis. Statistical analyses were performed using the unpaired Student's t test. A probability value of less than 0.05 was considered statistically significant.
RESULTS
Analysis of food intake
Nutritional data from the present survey including total energy, protein, fat and carbohydrate intakes, and the PFC ratios are shown in Table 3 . These values were compared with those in the 40-to 49-y-old general Japanese population (values from the 2006 survey), also shown in Table 3 . Total energy intake of the CTLN2 patients was 112% (2,445 Ϯ 430 kilocalories (kcal)) of control values. Comparing the energy ratio to total cal- Intake of vitamins and minerals was compared with the recommend daily allowance (RDA) in Table 4 . Mineral and vitamin intakes fulfilled the RDA in CTLN2 patients. The intake of zinc (13Ϯ2 mg) also satisfied the RDA (9 mg) in all patients. As for vitamins, all CTLN2 patients consumed 4 times more vitamin K and vitamin B 12 than the RDA.
Analysis of intake of food groups
It has been repeatedly reported that CTLN2 patients show an aversion to carbohydrate-rich foods and a preference for protein-and fat-rich foods. To clarify the types of dietary sources of carbohydrate, protein and fat, intakes of 18 food groups were investigated (Table  5 ). Cereal intake of the CTLN2 patients was 309Ϯ33 g/ d (590Ϯ95 kcal), which was 56% of the average cereal intakes of controls (553Ϯ197 g/d, pϽ0.01). Cereal was defined as rice, bread, noodles, and other wheat or millet products. Concerning other carbohydrate-rich foods, most patients in the present study reported only consuming a little of them, such as potatoes, fruits, sugar, and sweets. Carbohydrate-rich foods (except for cereals, mainly rice) accounted for only 50 kcal/d. As for the frequency of intake of potatoes and fruits, most CTLN2 patients consumed these foods 0-3 times a week. In addition, sugar intake in 4 patients was less than 2 g/d. Because 10-20 g of sugar are generally used in ordinary Japanese hospital meals, all 5 CTLN2 patients felt that the hospital meals were too sweet. Three of the 5 patients consumed sweets. Patient 3 reported consuming deep-fried food (chips) and other high fat sweets, chocolate and pudding twice a week. Patient 4 habitually ate chocolate and rice crackers once or twice a week. Patient 5 reported liking and consuming cheesecake and Yohkan (sweet jellied adzuki-bean paste) once every few months. As shown in Table 5 , a significant difference was seen in intake of dairy products (especially milk, yogurts and cheeses) compared to controls (309Ϯ186 g vs 73Ϯ119 g, respectively, pϽ0.01). When compared to age-matched controls, 4 patients consumed three times more dairy products, except for patient 2, who consumed many peanuts every day. The control values for consumption of dairy products by decade were 84Ϯ139 g/d for 30-to 39-y-olds, 73Ϯ119 g/d for 40-to 49-y-olds and 77Ϯ124 g/d for 50-to 59-y-olds. Due to high intake of milk as well as other dairy products in the patients in the present study, the calcium intake was calculated to be 1.7 times greater than in the controls (Table 4) . In addition, patients in the present study consumed significantly more nuts and seeds (pϽ0.01) and oil and fat (pϽ0.01) compared to controls. Sources of fat varied among the patients. Patient 1 consumed 12 g of cooking oil, slightly less than values for the controls (13 g), but he also consumed fat from protein-rich foods that were high in fat (cod roe, saury, blue-skin fish (such as sardines and mackerels), and rib meat). Patient 2 consumed 67% of his total energy from peanuts. Patients 3 and 4 consumed fat from cooking oil and dressing (mayonnaise 50-60 g/d). Patient 5 consumed fat from cooking oil, dressing and nuts.
DISCUSSION
The present data show that diet in CTLN2 patients aged 39-52 y was unique in that they consumed lowcarbohydrate and high-fat foods compared to the general Japanese population. Cereal intake was especially low in CTLN2 patients. In addition, most of the CTLN2 patients ate few fruits or sweets, although there were differences among patients surveyed. Saheki et al. surveyed daily food intakes of 18 citrin-deficient subjects aged 1-33 y, including one pre-CTLN2 patient aged 13 y (8, 9) . The mean PFC ratio of the 18 citrin-deficient subjects was 19Ϯ2% : 44Ϯ5% : 37Ϯ7%, and the average carbohydrate intake of the citrin-deficient subjects was approximately half that of age-and sexmatched Japanese controls (56Ϯ14%) (9) . Of particular interest in the present study was that the mean PFC ratio in CTLN2 patients (19Ϯ3% : 44Ϯ5% : 37Ϯ4%) was almost the same as that in younger citrin-deficient subjects (9) .
In the research on younger citrin deficiency subjects (9), significant differences were not observed in fat intake between citrin-deficient subjects and the Japanese controls. In other words, young citrin deficient subjects had a fat intake within 1 standard deviation of Japanese control subjects. Commonly, fat intake gradually declines with age in the general Japanese population. According to the 2006 survey (http://www.mhlw.go.jp/ bunya/kenkou/eiyou08/dl/01-05.pdf), the median (50 percentile) of the fat energy ratio was 30% in 1-to 29-yolds. However, this value was less than 25% in controls Ͼ30 y of age. The percentage of people with a fat intake of more than 35% of total energy was only 9% in 40-to 49-y-old men, and 4.3% in 50-to 59-y-old men. In the present study, the fat energy ratio of CTLN2 was more than 38%, and fat intakes were higher than in age-and sex-matched Japanese controls. Patients 2 and 5 had fat intakes more than 3 standard deviations from that of controls, and patient 4 was more than 2 standard deviations from the controls. Therefore, a high-fat diet was a characteristic in older CTLN2 patients than younger citrin-deficient subjects. In the 2006 survey, meat, oil and fat intakes peaked in 15-to 19-y-olds (male intake: 156.6 g/d of meat, 16.4 g/d of oil and fat) and the intakes decreased to less than 77% of the peak value in 40-49-y-olds. On the other hand, intake of soybean products, fish and vegetables increased with age. The present results, however, indicate that CTLN2 patients continued to consume high-fat meals regardless of age, although the source of the fat varied among patients. The fat intake of the present CTLN2 patients relative to the average values for controls was 196% ( Table 3 ), suggesting that fat was the main energy source in CTLN2 patients. A significant difference was also seen in intake of dairy products (pϽ0.01). In the 2006 survey, the peak age of intake of dairy products was observed in 7-to 14-y-olds (359.1 g/d) and decreased with age. In 40-to 49-y-olds, it was only 72.8 g/d. On the other hand, the present CTLN2 patients consumed three times more dairy products compared to control subjects of the same age. While the precise reason why CTLN2 patients prefer dairy products remains obscure, their preference may be associated with low carbohydrate and high fat content (the PFC ratio of milk is 20% : 50% : 30%).
Together with previous data reported by Saheki et al. (9) , the present results may indicate that aversion to carbohydrates is fundamentally seen regardless of a patient's age. Therefore, even in older patients, a highfat and high-protein diet seems to be required to compensate for lack of energy due to aversion to carbohydrates.
Carbohydrate aversion in citrin deficiency is thought to be quite unique in contrast to the protein aversion in other urea cycle enzyme deficiencies (9) . In citrin deficiency, carbohydrate metabolism facilitates accumulation of cytosolic NADH in hepatocytes, resulting in inhibition of ureagenesis by limitation of the supply of Asp for the urea cycle (3, 4) . Previous data have suggested that the toxicity of a high carbohydrate intake (8) , and indeed, intravenous infusion of a high glucose solution or the administration of a glycerol solution, result in severe hyperammonemia or rapid deterioration of encephalopathy leading to death in many CTLN2 patients (6, 16) . A CTLN2 patient (patient 3 in the present study) who had a rapid deterioration after consuming a conventional low-protein diet for hepatic encephalopathy, in which the energy ratio of carbohydrates in total diet energy was around 75%, has been previously reported (7) . It has also been found that oral sucrose administration exacerbated hyperammonemia in citrin/mitochondrial glycerol 3-phosphate dehydrogenase double knockout mice, an animal model of human citrin deficiency (17) . Therefore, high carbohydrate intake can deteriorate hepatic encephalopathy in CTLN2 patients. The efficacy of a carbohydraterestricted diet in citrin deficiency patients has been described in a few patients (7, 18, 19) . In patient 3 in the present study, induction of a low-carbohydrate diet (PFC ratio 15% : 40% : 45%) was therapeutically effective against encephalopathy (7).
In conclusion, CTLN2 patients in this study consumed low-carbohydrate, high-fat, and high-protein diets, similar to younger individuals with citrin deficiency, and therefore, it appears that the PFC ratio of citrin-deficient subjects is not influenced by age or CTLN2-onset. Carbohydrates were strictly adjusted by total intake of cereals in our patients. A conventional hospital diet for hyperammonemia may be risky in treatment of CTLN2 patients because of its high carbohydrate content. A low-carbohydrate and high-fat diet is recommended for patients with CTLN2 and from results of the nutrition survey in the present study and data reported previously (7-9, 19), 1,720-kcal meals have been recently served with 130 g boiled rice and 70 g protein (PFC ratio15% : 45% : 40%) as a basic hospital diet for CTLN2 patients in our hospital. However, since our data was obtained from a small number of patients, further study may be needed to confirm our results and to establish a more appropriate diet for CTLN2 patients.
